Financial Performance - The company's operating revenue for Q1 2024 was ¥107,742,152.82, representing a year-on-year increase of 14.20%[4] - Net profit attributable to shareholders reached ¥8,592,459.98, a significant increase of 275.02% compared to the same period last year[4] - The basic earnings per share (EPS) was ¥0.10, reflecting a growth of 278.89% year-on-year[4] - In Q1 2024, the company's net profit reached CNY 8,301,418.40, a significant increase from CNY 1,968,179.53 in Q1 2023, representing a growth of approximately 320.5%[19] - The operating profit for Q1 2024 was CNY 8,352,574.38, compared to CNY 1,174,381.71 in the same period last year, indicating a substantial increase of about 610.5%[19] - The total comprehensive income for Q1 2024 was CNY 8,301,418.40, compared to CNY 1,968,179.53 in Q1 2023, reflecting a growth of approximately 320.5%[20] Assets and Liabilities - The total assets at the end of the reporting period were ¥892,062,414.27, a decrease of 2.06% from the end of the previous year[5] - Cash and cash equivalents decreased to RMB 237,756,922.41 as of March 31, 2024, down from RMB 340,636,874.91 at the end of 2023, a decline of 30.2%[14] - Total assets as of March 31, 2024, amounted to RMB 892,062,414.27, a decrease from RMB 910,804,686.67 at the end of 2023[17] - The company's total liabilities decreased slightly to RMB 208,624,005.05 from RMB 210,344,370.61 at the end of 2023[16] - The company’s equity attributable to shareholders decreased to RMB 664,518,707.28 from RMB 681,249,572.54, reflecting a decline of 2.4%[17] Cash Flow - The net cash flow from operating activities was ¥6,771,725.98, with a significant increase attributed to higher revenue and improved collections[7] - Cash flow from operating activities totaled CNY 90,481,856.81 in Q1 2024, up from CNY 65,747,741.12 in Q1 2023, reflecting a growth of approximately 37.5%[24] - The company reported a net cash outflow from investing activities of CNY -137,566,455.18 in Q1 2024, compared to CNY -6,995,411.87 in Q1 2023, indicating a significant increase in investment expenditures[24] - The cash and cash equivalents at the end of Q1 2024 were CNY 151,665,990.41, down from CNY 322,933,683.29 at the end of Q1 2023, showing a decrease of approximately 53.1%[25] - The total cash inflow from financing activities in Q1 2024 was CNY 14,221,100.15, down from CNY 20,839,283.67 in Q1 2023, indicating a decrease of approximately 31.7%[25] Research and Development - Research and development (R&D) expenses totaled ¥7,280,178.37, which is a decrease of 3.31% compared to the previous year[4] - The proportion of R&D expenses to operating revenue was 6.76%, down by 1.22 percentage points year-on-year[4] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 6,400[10] Other Notable Information - The company reported non-recurring gains of ¥300,509.81 during the quarter, primarily from financial asset disposals and government subsidies[7] - The company reported a credit impairment loss of CNY -691,891.34 in Q1 2024, compared to CNY -1,125,771.05 in Q1 2023, showing an improvement in credit quality[19] - The company has not reported any new product launches or significant market expansion strategies during this quarter[13] - The company reported a significant increase in trading financial assets, rising to RMB 93,427,039.16 from RMB 30,978,054.79, indicating a strategic shift in asset management[14]

Financial Performance - The company experienced a significant decline in revenue due to a weak domestic and international consumer market, resulting in a net loss for 2023[4]. - The company's operating revenue for 2023 was CNY 399,591,411.29, a decrease of 20.29% compared to CNY 501,318,873.89 in 2022[24]. - The net profit attributable to shareholders for 2023 was a loss of CNY 12,779,476.42, representing a decline of 123.19% from a profit of CNY 55,108,289.49 in 2022[24]. - The net cash flow from operating activities decreased by 30.86% to CNY 52,272,350.38 in 2023, down from CNY 75,606,095.53 in 2022[24]. - Basic earnings per share for 2023 were -CNY 0.15, a decrease of 124.19% compared to CNY 0.62 in 2022[25]. - The weighted average return on equity for 2023 was -1.83%, a decrease of 9.48 percentage points from 7.65% in 2022[25]. - The company's main business revenue decreased by 20.60% to RMB 396.63 million, while the main business cost reduced by 19.05% to RMB 298.88 million[133]. - The company reported a foreign exchange loss of RMB -3.33 million during the reporting period, which may increase with the growth of export business[127]. - The company faced risks related to a single major customer, which could adversely affect market promotion and operational performance if the customer fails to meet expectations[125]. Product Development and Innovation - The company plans to develop new products and expand into communication, energy storage, and automotive sectors to create new profit growth points[4]. - Research and development investments increased by 12%, focusing on innovative technologies in energy efficiency[15]. - The company has filed 55 new patent applications during the reporting period, including 17 invention patents[38]. - The company has developed a smart wearable air conditioning product to address cooling needs for outdoor workers in high-temperature environments[41]. - The company is focusing on the development of high-performance micro refrigeration devices for communication applications, addressing specific technical demands[76]. - The company is focusing on innovative designs for ceramic packaging to enhance its competitiveness in the ceramic industry[110]. - The company is expanding its product line to include wearable cooling garments, leveraging liquid cooling technology for effective human thermal exchange[102]. Market Expansion and Strategy - The company is expanding its market presence in Southeast Asia, targeting a 10% market share by the end of 2024[15]. - A strategic acquisition of a local competitor is expected to enhance the company's product offerings and increase market penetration by 15%[15]. - The company aims to transform existing thermoelectric device customers into thermoelectric system customers to achieve higher product added value[157]. - Future marketing strategies will focus on leveraging partnerships with well-known enterprises to accelerate market penetration and increase brand recognition[156]. - The company is committed to enhancing its smart manufacturing capabilities through increased automation and information technology investments[155]. Financial Governance and Shareholder Relations - The board approved a profit distribution plan that includes no cash dividends or capital reserve transfers due to the company's losses in 2023[6]. - The company has established a cash dividend policy, ensuring that at least 20% of the distributable profits are distributed in cash if there are no major investment plans or cash expenditures[195]. - In 2023, due to losses, the company plans not to distribute cash dividends or issue bonus shares, pending approval from the annual shareholders' meeting[198]. - The company has held three shareholder meetings during the reporting period, ensuring compliance with legal and regulatory requirements[163]. - The company has established a governance structure that promotes transparency and protects the rights of all shareholders, particularly minority shareholders[167]. Operational Efficiency and Risk Management - The implementation of a new ERP system is projected to improve operational efficiency by 20% in the next fiscal year[14]. - The company will enhance production efficiency through lean production improvement projects and the implementation of digital systems like SAP ERP, MES, and WMS[158]. - The company plans to enhance accounts receivable management to mitigate bad debt risks in the future[37]. - The company will continue to face various risks in its operations, as detailed in the management discussion and analysis section of the report[4]. Research and Development Focus - The total R&D investment for the year was approximately ¥31.55 million, a decrease of 7.12% compared to the previous year[89]. - The company has established a comprehensive semiconductor thermoelectric technology R&D testing platform, including high-end testing equipment for material performance and system testing, recognized as a provincial-level enterprise technology center[117]. - The company has a strong R&D team and extensive customization experience, enabling rapid response to customer needs and gaining high recognition from clients[41]. - The company is committed to promoting semiconductor thermoelectric technology and expanding its market presence[34]. Employee and Management Structure - The company has a total of 1,278 employees, with 1,010 in the parent company and 268 in major subsidiaries[191]. - The company has established a remuneration and assessment committee to oversee the compensation plans for directors and senior management[180]. - The average salary of R&D personnel rose from 11.84 million to 12.01 million RMB, indicating a focus on retaining skilled talent[113]. - The company emphasizes employee training and development, establishing a dedicated training system for various roles[193].

广东富信科技股份有限公司 2023 年度独立董事述职情况报告 本人作为广东富信科技股份有限公司（以下简称"公司"）的独立董事，2023 年度严格按照《中华人民共和国公司法》（以下简称"《公司法》"）、《中华 人民共和国证券法》（以下简称"《证券法》"）、《上海证券交易所科创板股 票上市规则》（以下简称"《上市规则》"）、《上市公司独立董事管理办法》 等法律法规，以及《广东富信科技股份有限公司章程》（以下简称"《公司章程》"）、 《公司独立董事工作制度》等规定，认真负责、忠实勤勉地履行职责，积极出席 相关会议，认真审议董事会的各项议案，对公司的重大事项发表独立意见，充分 发挥独立董事的专业职能，维护公司整体利益及全体股东特别是中小股东的合法 权益，现将本人 2023 年度履行职责情况报告如下： 一、独立董事的基本情况 （一）个人工作履历、专业背景以及兼职情况 潘春晓，中国国籍，无永久境外居留权。1975年6月出生，2004年6月毕业于 中山大学法律专业，本科学历，律师。主要工作经历如下：1997年7月至1999年6 月就职江苏省连云港市佳友贸易公司；1999年8月至2004年12月就职于广东南国 德赛律师事务所 ...

一、募集资金基本情况 2021 年 2 月 24 日，经中国证券监督管理委员会《关于同意广东富信科技股 份有限公司首次公开发行股票注册的批复》（证监许可〔2021〕552 号）同意， 公司获准向社会公开发行人民币普通股 2,206.00 万股，每股发行价格为人民币 15.61 元，本次发行募集资金总额 344,356,600.00 元，扣除承销及保荐费用、律 师费用、审计及验资费用、发行登记费用以及其他交易费用 36,781,931.54 元（不 含税）后，实际募集资金净额为人民币 307,574,668.46 元。上述资金情况已经中 审众环会计师事务所（特殊普通合伙）验证并出具（众环验字[2021]0500004 号） 验资报告。 公司对募集资金专户存储，并与保荐机构中泰证券股份有限公司及存储募集 资金的监管银行签订了募集资金专户监管协议。具体情况详见公司于 2021 年 3 月 31 日披露于上海证券交易所网站（www.sse.com.cn）的《富信科技首次公开 发行股票科创板上市公告书》。 二、募集资金使用情况和结余情况 截至 2023 年 12 月 31 日，公司已累计使用募集资金 178,055,0 ...

证券代码：688662 证券简称：富信科技 公告编号：2024-026 广东富信科技股份有限公司 关于开展 2024 年外汇远期结售汇业务的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 广东富信科技股份有限公司（以下简称"公司"）于 2024 年 4 月 25 日召开 了第四届董事会第十三次会议、第四届监事会第十次会议，审议通过了《关于开 展 2024 年外汇远期结售汇业务的议案》，同意公司（含子公司，下同）自股东 大会审议通过之日起 12 个月内开展外汇远期结售汇业务，远期结售汇开展外币 金额不得超过等值 5,000 万美元（额度范围内资金可滚动使用）。该事项尚需股 东大会审议。现将相关情况公告如下： （一）交易目的 为了有效规避外汇市场风险，防范汇率大幅波动对公司经营业绩造成的不利 影响，提高外汇资金使用效益，合理降低财务费用，公司结合 2024 年境外销售 规模，计划与银行开展外汇远期结售汇业务。 外汇远期结售汇业务是指与银行签订外汇远期结售汇合同，约定将来办理结 汇或售汇的外汇币种、金额、汇率和期限，到期再 ...

证券代码：688662 证券简称：富信科技 公告编号：2024-028 广东富信科技股份有限公司 关于核销部分应收款项的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 广东富信科技股份有限公司（以下简称"公司"）于2024年4月25日召开 了第四届董事会第十三次会议、第四届监事会第十次会议，审议通过了《关于核 销部分应收款项的议案》。由于客户Sleepme Inc.（以下简称"Sleepme"）启动 ABCs程序，且其债务远大于资产价值，公司作为无担保债权人无法获得任何债 权清偿，根据企业会计准则的相关规定，对中信保理赔后的最大应收账款余额 486.40万美元，折算人民币3,446.97万元，全额进行坏账核销，导致公司2023年 年度净利润大幅下滑，出现亏损。 一、本次核销应收款项的情况概述 根据《企业会计准则》以及公司财务管理制度等相关规定，为客观、公允、 真实地反映公司2023年度财务状况及经营成果，基于谨慎性原则，依法合规、规 范操作，公司对截至2023年12月31日确定无法收回的应收账款做核销 ...

证券代码：688662 证券简称：富信科技 公告编号：2024-022 广东富信科技股份有限公司 2023 年度募集资金存放与实际使用情况的 专项报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 广东富信科技股份有限公司（以下简称"公司"）根据《上市公司监管指引 第2号——上市公司募集资金管理和使用的监管要求》《上海证券交易所科创板 上市公司自律监管指引第1号——规范运作》以及《广东富信科技股份有限公司 募集资金管理办法》（以下简称"《管理办法》"）等相关规定，结合公司实际 情况，就2023年度募集资金存放与实际使用情况作如下专项报告： 一、募集资金基本情况 2021年2月24日，经中国证券监督管理委员会《关于同意广东富信科技股份 有限公司首次公开发行股票注册的批复》（证监许可〔2021〕552号）同意，公 司获准向社会公开发行人民币普通股2,206.00万股，每股发行价格为人民币 15.61元，本次发行募集资金总额344,356,600.00元，扣除承销及保荐费用、律师 费用、审计及验资费用、发行登记费用以及其他交易 ...

中泰证券股份有限公司（以下简称"中泰证券"或"保荐机构"）作为广东 富信科技股份有限公司（以下简称"富信科技"或"公司"）首次公开发行股票 并在科创板上市的保荐机构，根据《证券发行上市保荐业务管理办法》《上海证 券交易所科创板股票上市规则》《上海证券交易所科创板上市公司自律监管指引 第 1 号——规范运作》等有关规定，对富信科技预计 2024 年度日常性关联交易 事项进行了认真、审慎的核查，核查情况如下： 一、日常关联交易基本情况 中泰证券股份有限公司 关于广东富信科技股份有限公司 预计 2024 年度日常性关联交易的核查意见 （一）日常关联交易履行的审议程序 广东富信科技股份有限公司（以下简称"公司"）于 2024 年 4 月 25 日召开 了第四届董事会第十三次会议、第四届监事会第十次会议，审议通过了《关于预 计 2024 年度日常性关联交易的议案》，预计 2024 年度本公司及控股公司与其他 关联方之间发生的与日常经营相关联的交易总额不超过 640 万元。关联董事林东 平回避表决，其余非关联董事一致同意该议案，审议程序符合相关法律法规的规 定。 公司董事会审计委员会经认真审核后，对本次日常关联交易预计事 ...

广东富信科技股份有限公司 关于续聘 2024 年度财务审计机构及内控审计机构的 公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 证券代码：688662 证券简称：富信科技 公告编号：2024-024 拟聘任的会计师事务所名称：中审众环会计师事务所（特殊普通合伙） 广东富信科技股份有限公司（以下简称"公司"）于 2024 年 4 月 25 日召开 第四届董事会第十三次会议，审议通过了《关于续聘公司 2024 年度财务审计机 构及内控审计机构的议案》，公司拟续聘中审众环会计师事务所（特殊普通合伙） （以下简称"中审众环"）为公司 2024 年度财务审计机构及内控审计机构。现 将具体情况公告如下： 一、拟聘任会计师事务所的基本情况 （一）机构信息 1、基本信息 （1）名称：中审众环会计师事务所（特殊普通合伙）。 （2）成立日期：中审众环始创于 1987 年，是全国首批取得国家批准具有从 事证券、期货相关业务资格及金融业务审计资格的大型会计师事务所之一。2013 年 11 月，按照国家财政部等有关要求转制为特 ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、董事会会议召开情况 广东富信科技股份有限公司（以下简称"公司"）第四届董事会第十三次会 议于 2024 年 4 月 25 日在公司办公楼五楼一号会议室以现场与通讯相结合的方 式召开。本次会议通知以及相关材料已于 2024 年 4 月 15 日通过书面方式送达各 位董事。 本次会议由公司董事长刘富林召集和主持，应出席董事 9 人，实际出席董事 9 人。本次会议采用现场与通讯相结合的表决方式，会议的召集、召开与表决程 序符合《中华人民共和国公司法》（以下简称"《公司法》"）、《广东富信科 技股份有限公司章程》（以下简称"《公司章程》"）的规定，会议形成的决议 合法、有效。 证券代码：688662 证券简称：富信科技 公告编号：2024-020 广东富信科技股份有限公司 第四届董事会第十三次会议决议公告 二、董事会会议审议情况 （一）审议通过《关于<2023 年度总经理工作报告>的议案》 1、主要内容：经审议，公司总经理总结 2023 年工作而形成的《2023 年度总 经理工作 ...